bioRxivImmunologyPreprint
Loss of B cell tolerance at the T2/T3a B cell transition is a convergent pathogenic mechanism in common variable immunodeficiency
Kirsty HillieriD, Grace J. YueniD, Anson Hui, Suparna KumariD, Priyamvada Guha RoyiD, Joseph T. McColgan, Kimberly S. ZaldanaiD, Hugues Allard‐ChamardiD, Katie Premo, Naoki KanekoiD, Nicole Ingram, Sara BarmettleriD, Musie S GhebremichaeliD, Jolan Eszter WalteriD, Cory A. PeruginoiD, Jishnu DasiD, Jocelyn R. FarmeriD, Shiv S PillaiiD
Abstract
Many patients with common variable immunodeficiency (CVID), including those with CTLA4 deficiency, NFKB1 variants and activated PI3K-delta syndrome (APDS), develop autoimmunity that is refractory to treatment. Despite this shared clinical phenotype, a unifying mechanism for the breakdown of B cell tolerance across monogenic forms of CVID has not been established. Here, we demonstrate that patients with loss-of-function NFKB1 variants, like those with CTLA4 variants and APDS, exhibit dysregulated CD4+ T cell expansion, accumulation of transitional B cells, and a relative lack of follicular B cells. In patients with monogenic CVID and clinical autoimmunity, we observed a relative expansion of transitional and activated naive (aN: CD21loCD11chi) B cells in peripheral blood accompanied by a marked increase in the frequency of VH4-34 expressing autoreactive 9G4+ B cells, which expanded between T2 and T3a transitional B cell stages. Single-cell transcriptomic and B cell receptor analysis further revealed a marked expansion of activated T1/2, T3 and extrafollicular activated naive and double negative (DN: IgD-CD27-) B cell subsets in APDS patients. Notably, one B cell subset appeared exclusively in the APDS disease state, characterized by high oxidative phosphorylation in transitional B cells, specifically. In APDS patients, we also observed a clonal expansion of specific extrafollicular class-switched DN B cells, which were clonally derived from activated transitional B cells. DN B cells were also identified in APDS lung tissue, consistent with the contribution of activated, extrafollicularly-derived B cells to tissue inflammation. Together, these findings suggest that in many patients with CVID and autoimmune features, premature activation of autoreactive transitional T2 and T3a B cells induces the survival and expansion, rather than the tolerization and elimination, of self-reactive B cells. This process leads to extrafollicular expansion of autoreactive B cells capable of tissue infiltration. One Sentence SummaryLoss of transitional B cell tolerance and extrafollicular expansion of autoreactive B cells drive autoimmunity in monogenic causes of CVID.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency
G. Milardi, B. Di Lorenzo, … C. Cancrini·bioRxiv·Jun 15, 2021
- Integrated Multi-omics Analyses of NFKB1 patients B cells points towards an up regula-tion of NF-κB network inhibitors
N. Camacho-Ordonez, N. Ramirez, … B. Grimbacher·bioRxiv·Nov 22, 2022
- Single-Cell Atlas of Common Variable Immunodeficiency reveals germinal center-associated epigenetic dysregulation in B cell responses
J. Rodriguez-Ubreva, A. Arutyunyan, … E. Ballestar·bioRxiv·Dec 20, 2021
- CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
M. M. Muthana, X. Du, … Y. Liu·bioRxiv·Mar 1, 2023
- A PATHOGENIC NFKB2 VARIANT CAUSES COMBINED IMMUNODEFICIENCY WITH THYMIC AND PERIPHERAL LYMPHOID DEFECTS IN RATS
Séverine Remy, Laurent Tesson, … Ignacio Anegón·bioRxiv·Oct 8, 2026
- Extrafollicular responses are sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus
L. F. Voss, A. J. Howarth, … S. E. Degn·bioRxiv·Mar 4, 2022